Physician profile
Joseph L Parrish
NPI 1518902584
$1,471.68
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,083 · 2020: $235 · 2021: $154.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $149.79 | 2019-2020 | |
| Abiomed | $125.00 | 2021 | |
| Boston Scientific Corporation | $124.37 | 2019 | |
| Opsens INC. | $117.32 | 2019 | |
| Janssen Pharmaceuticals, INC | $111.83 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $91.24 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $89.59 | 2019-2020 | |
| Amgen INC. | $78.05 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $69.39 | 2019 | |
| Sanofi-Aventis U.S. LLC | $67.41 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.72 | 2019-2020 | |
| Amarin Pharma, INC. | $56.10 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.45 | 2019-2021 | |
| Pfizer INC. | $50.99 | 2019-2020 | |
| Abbott Laboratories | $36.62 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $31.38 | 2019-2020 | |
| Chiesi USA, INC. | $23.96 | 2019 | |
| Irhythm Technologies, INC. | $20.35 | 2020 | |
| Lundbeck LLC | $17.11 | 2020 | |
| Edwards Lifesciences Corporation | $15.01 | 2021 | |
| Bardy Diagnostics, INC. | $14.00 | 2019 | |
| Braemar Manufacturing, LLC | $13.74 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.08 | 2019 | |
| Astellas Pharma US INC | $13.08 | 2019 | |
| Livanova USA, INC. | $11.89 | 2019 | |
| Gilead Sciences, INC. | $11.21 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Parrish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.